CCCC Competitors & Alternatives
Compare C4 Therapeutics Inc with similar stocks in the same industry
Biotechnology
CCCC
Main Stock$3.13
Tradestie Score
52
Market Cap
$153.02M
Revenue Growth
0.0%
Analyst Upside
+310.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 54 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$6.81
|
$422.50M | - | 56 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$50.44
|
$410.79M | - | 57 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$12.62
|
$407.71M | - | 57 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.73
|
$386.68M | - | 55 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.46
|
$382.04M | - | 62 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.48
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.89
|
$354.45M | - | 56 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$39.23
|
$353.70M | 410.0 | 38 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.44
|
$350.98M | - | 63 | Compare |
More CCCC Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry